// App-Quantinova.ai

P221 : Treatment fidelity in the Gait Rehabilitation in Early Rheumatoid Arthritis Trial (GREAT) feasibility study

Researchers

Presenter

  • Emma Godfrey

Principal Investigators

  • Mandeep Sekhon

  • Gordon Hendry

  • Nadine E Foster

  • Samantha Hider

  • Marike van der Leeden

  • Helen Mason

  • Alex McConnachie

  • Iain McInnes

  • Aimie Patience

  • Catherine Sackley

  • Martin Steultjens

  • Anita Williams

  • Jim Woodburn

  • Lindsay Bearne

Medical Centers

  • Department of Population Health Sciences, King’s College London, London, UNITED KINGDOM

  • Health Psychology Section, King's College London, London, UNITED KINGDOM

  • Health and Life Sciences, Glasgow Caledonian University, Glasgow, UNITED KINGDOM

  • Research Institute for Primary Care and Health Sciences, Keele University, Keele, United Kingdom

  • School of Primary, Community and Social Care, Keele University, Staffordshire, United Kingdom

  • Haywood Academic Rheumatology Centre, Midlands Partnership Foundation Trust, Staffordshire UK, UNITED KINGDOM

  • Rehabilitation Medical Clinic, VU University Amsterdam, Amsterdam, NETHERLANDS

  • Health and Life Sciences, Glasgow Caledonian University, Glasgow, UNITED KINGDOM

  • Robertson Centre of Biostatistics, University of Glasgow, Glasgow, United Kingdom

  • Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK

  • School of Health & Society, University of Salford, Salford, UNITED KINGDOM

Locations

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A